Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.


Fléchon A., Morales-Barrera R., Powles T., Alva A., Özgüroğlu M., Csöszi T., ...Daha Fazla

Clinical cancer research : an official journal of the American Association for Cancer Research, 2024 (SCI-Expanded, Scopus) identifier